Cargando…
Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol
Background: While precision medicines targeting genetic mutations and alterations in non-small cell lung cancer (NSCLC) have been available since 2010, their adoption into clinical practice has been slow. Evidence suggests that a number of barriers, such as insufficient clinician knowledge, a need f...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934686/ https://www.ncbi.nlm.nih.gov/pubmed/29780892 http://dx.doi.org/10.12688/wellcomeopenres.13976.1 |